Testosterone Lawsuits to Be Addressed As Federal Litigation Prepares to Convene Case Management Conference, Bernstein Liebhard LLP Reports

Share Article

The Firm is representing a number of testosterone lawsuit plaintiffs whose claims are pending in this proceeding, all of whom allegedly suffered serious cardiovascular problems due to their use of low testosterone therapy medications.

Free Case Review
We look forward to Friday’s conference, as it will likely provide up-to-date information on the progress of discovery and other important developments in the litigation.

Hundreds of testosterone lawsuits (http://www.testosteronelawsuithub.com/) filed on behalf of men who allegedly suffered serious cardiovascular problems due to their use of low testosterone therapy medications continue to move forward in the federal multidistrict litigation now underway in U.S. District Court, Northern District of Illinois, Bernstein Liebhard LLP reports. According to court documents, the growing litigation will be discussed on Friday, February 20th, when the Court convenes its next Case Management Conference. The Conference will begin at 2:30 p.m. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm is pleased to see the federal litigation progressing, as we are representing a number of testosterone lawsuit plaintiffs in the proceeding. We look forward to Friday’s conference, as it will likely provide up-to-date information on the progress of discovery and other important developments in the litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free case reviews to men who may have been harmed by prescription low testosterone treatments.

Testosterone Litigation
Court documents indicate that more than 1,000 testosterone treatment lawsuits have been filed in the litigation underway in the Northern District of Illinois. Lawsuits involving this class of medications have been mounting in U.S. courts since the Food & Drug Administration (FDA) announced on January 31, 2014 that it was investigating the cardiovascular side effects associated with low testosterone therapy. The FDA’s review is ongoing, and last September a panel of medical experts advising the agency recommended that larger studies be conducted to better assess their heart risks. The same panel also advised that the labeling for low testosterone medications be updated to make it clear that they haven’t been proven to be effective treatments for low libido, fatigue and other issues typically experienced by men as they age.*

According to court records, all of the testosterone lawsuits pending in Illinois were filed on behalf of men who allegedly suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other life-threatening heart problems due to treatment with prescription testosterone drugs. Plaintiffs allege that the manufacturers of these medications knowingly concealed these risks from the public, and failed to warn doctors and patients about the potential for serious heart complications. The lawsuits also claim that marketing initiatives which positioned the drugs as effective treatments for age-related symptoms induced healthy men to use the potentially dangerous medications, even in the absence of a true medical need.

Men who allegedly suffered serious cardiovascular events due to their use of prescription testosterone treatments may be entitled to compensation for their injury-related damages. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*http://www.reuters.com/article/2014/09/17/us-usa-health-testosterone-idUSKBN0HC2C320140917, Reuters, September 17, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.testosteronelawsuithub.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website